Regulators ultimately stepped in. By 1984, the drug was listed as Schedule I from the US in addition to a Class B drug in the UK, which makes its manufacturing and distribution illegal completely. one mutations on allopregnanolone-mediated potentiation in the GABAAR noticed in this examine are in concordance with https://methaqualone-and-propoxyp79727.liberty-blog.com/29737766/top-guidelines-of-methaqualone-drug-classification